METHODS OF USE OF ANTI-SORTILIN ANTIBODIES

The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof. La pré...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ROSENTHAL, ARNON, PAUL, ROBERT, WARD, MICHAEL F, LONG, HUA, YEH, FELIX LEEJIA, LIAO, YIJIE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof. La présente divulgation concerne de manière générale l'utilisation d'anticorps qui se lient spécifiquement à un ou à plusieurs épitopes dans une protéine sortiline, par exemple la sortiline humaine ou la sortiline de mammifère, afin de traiter et/ou de retarder la progression d'une maladie, d'un trouble ou d'une lésion chez un individu le nécessitant.